Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1481 results found
2023 ∙ Hu, Y. Wang, Y. Shao, T. Tang, W. Hu, K. Zhou, Y. Miao, L. Liu, J. Wang, B. Yu, W.
Safety and immunogenicity of heterologous ChAdOx1-nCoV19 and BNT162b2 vaccination: A meta-analysis of the heterologous COVID-19 vaccination outcomes
Adults Older adults COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Fan, X. Zhao, Y. Wu, F. Yuan, Y. Lang, B. Yin, D. Xu, Z. Jiang, S. Zou, H. Yuan, J. Sun, C.
Safety and Immunogenicity of SARS-CoV-2 Vaccines in People Living with HIV: A Systematic Review and Meta-analysis of Real-World Studies
Adults Older adults COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Kandeel, M. Morsy, M. A. Abd El-Lateef, H. M. Marzok, M. El-Beltagi, H. S. Al Khodair, K. M. Albokhadaim, I. Venugopala, K. N.
Safety and immunogenicity of the ChAdOx1, MVA-MERS-S, and GLS-5300 DNA MERS-CoV vaccines
Adults COVID-19 Efficacy/effectiveness Safety Administration
Rating:
Critically low
2023 ∙ Stefanou, M. I. Palaiodimou, L. Theodorou, A. Christodoulou, M. V. Tzartos, J. S. Tzanetakos, D. Kitsos, D. Chondrogianni, M. Zouvelou, V. Dardiotis, E. Tzavellas, E. Syrigou, E. Benetou, V. Paraskevas, G. P. Tsiodras, S. Tsivgoulis, G. Giannopoulos, S.
Safety of COVID-19 vaccines in multiple sclerosis: A systematic review and meta-analysis
All age groups COVID-19 Safety
Rating:
Moderate
2023 ∙ van de Pol, N. Pan, Q. Derikx, Laap Bakker, L. van der Woude, C. J. de Vries, A. C.
SARS-CoV-2 breakthrough infections after COVID-19 vaccination in patients with inflammatory bowel disease: a systematic review and meta-analysis
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Liang, Y. Sun, Q. Liu, Q. Pang, Y. Tang, S.
SARS-CoV-2 incidence, seroprevalence, and COVID-19 vaccination coverage in the homeless population: a systematic review and meta-analysis
All age groups COVID-19 Coverage
Rating:
Not applicable
2023 ∙ Jing, X. Han, M. Wang, X. Zhou, L.
SARS-CoV-2 vaccine breakthrough infection in the older adults: a meta-analysis and systematic review
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Søndergaard, M. H. Thavarajah, J. J. Churchill Henson, H. Wejse, C. M.
SARS-CoV-2 vaccine immunogenicity for people living with HIV: A systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Y. Elzouki, A. N. Elshafei, M. N. Aziz, A. Elzouki, I. Waheed, M. A. Farooqui, K. Azad, A. M. Habas, E. Danjuma, M. I.
Seroconversion and safety of Covid-19 vaccines in patients with chronic liver disease and liver transplant: A systematic review
Adults COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2023 ∙ Gkoufa, A. Lekakis, V. Papatheodoridis, G. Cholongitas, E.
Seroconversion following a booster dose of COVID-19 vaccine in liver transplant recipients. A systematic review and meta-analysis
Adults Older adults COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
Loading...